The potential effect of some newer risk factors for atherosclerosis on aortic distensibility in subjects with and without type 2 diabetes

Diabetes Care

Volumn 29, Issue 8, 2006, Pages 1926-1928

  Papazafiropoulou, Athanasia ^a   Tentolouris, Nicholas ^a,c   Moyssakis, Ioannis ^b   Perrea, Despoina ^a   Katsilambros, Nicholas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS;

AORTIC DISEASES; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33746633281     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0154     Document Type: Article

References (16)

1. Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension 26:869-879, 1995
2. Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P: Distensibility of ascending aorta: comparison of invasive and non-invasive techniques in healthy men and men with CAD. Eur Heart J 11:990-996, 1990
3. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 24:S5-S20, 2001
4. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF: Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 68:50-58, 1983
5. Dart A, Silagy C, Dewar E, Jennings G, McNeil J: Aortic distensibility and left ventricular structure and function in isolated systolic hypertension. Eur Heart J 14:1465-1470, 1993
6. Kannel WB, Anderson K, Wilson PW: WBC count and cardiovascular disease: insights from the Framingham Study. JAMA 267:1253-1256, 1992
7. Brown DW, Giles WH, Croft JB: White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54:316-322, 2001
8. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE: Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96:1102-1108, 1997
9. Lehmann ED, Hopkins KD, Gosling RG: Increased aortic stiffness in women with NIDDM. Diabetologia 39:870-871, 1996
10. Chappey O, Dosquet C, Wautier MP, Wautier JL: Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27:97-108, 1997
11. Lehto S, Niskanen L, Ronnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29:635-639, 1998
12. Tseng CH: Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabet Med 21:724-729, 2004
13. Baker JF, Krishnan E, Chen L, Schumacher HR: Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 118:816-826, 2005
14. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1629-1632, 2006
15. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr, the Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567-1577, 2006
16. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V: C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality: a population-based, prospective study. Thromb Haemost 95:511-518, 2006